Position in PFE
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,155,936
-$200,159 QoQ
Shares Held
48,004
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,242
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 66%
Shared 34%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Citizens National Bank Trust Department holds $40,807,071 across 11 Drug Manufacturers - General names. PFE ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
53,024 | $13,466,505 | |
| 2 | ABBV |
AbbVie Inc.
|
41,402 | $10,418,399 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,606 | $5,860,371 | |
| 4 | AMGN |
Amgen Inc
|
9,432 | $3,415,515 | |
| 5 | AZN |
Astrazeneca PLC
|
13,045 | $2,473,592 | |
| 6 | LLY |
ELI LILLY & Co
|
1,809 | $2,169,769 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
26,349 | $1,518,229 | |
| 8 | PFE |
Pfizer Inc
This page
|
48,004 | $1,155,936 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,155,936 | 48,004 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,356,095 | 48,294 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,159,219 | 46,555 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,260,368 | 49,465 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,117,536 | 46,103 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,158,240 | 45,708 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,232,000 | 46,438 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,527,134 | 52,769 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,326,643 | 47,414 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,369,851 | 49,364 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,494,632 | 51,915 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $1,845,578 | 55,640 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,033,906 | 55,450 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $1,702,420 | 41,726 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,155,974 | 42,076 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,852,185 | 42,326 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,292,554 | 43,726 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,167,465 | 22,551 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,349,351 | 22,851 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,226,583 | 51,769 | Shares | Other | 2021-11-08 | |
| 2021-06-30 | $2,320,973 | 59,269 | Shares | Other | 2021-08-05 | |
| 2021-03-31 | $2,300,531 | 63,498 | Shares | Other | 2021-05-10 | |
| 2020-12-31 | $2,368,649 | 64,348 | Shares | Other | 2021-02-11 | |
| 2020-09-30 | $2,367,074 | 64,498 | Shares | Other | 2020-11-09 | |
| 2020-06-30 | $2,009,351 | 61,448 | Shares | Other | 2020-08-06 | |
| 2020-03-31 | $2,005,659 | 61,448 | Shares | Other | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||